Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies

INTRODUCTION: This analysis evaluated the efficacy and safety of dulaglutide in Chinese patients with type 2 diabetes (T2D) aged ≥ 60 and < 60 years. METHODS: This post hoc analysis included patients with T2D enrolled in two phase 3 clinical trials AWARD-CHN1 (NCT01644500) and AWARD-CHN2 (NCT0164...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuang, Jian, Zhu, Jiankun, Liu, Siying, Li, Quanmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509013/
https://www.ncbi.nlm.nih.gov/pubmed/32857293
http://dx.doi.org/10.1007/s13300-020-00910-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509013/
https://www.ncbi.nlm.nih.gov/pubmed/32857293
http://dx.doi.org/10.1007/s13300-020-00910-1

Ejemplares similares